Release Date: 10/01/12 17:00 Summary: MRX Corporate Governance Statement Price Sensitive: No Download Document 172.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%